3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Multiple Sclerosis (MS): new trials by email Literature Review of Multiple Sclerosis (MS) trials Research Report on Multiple Sclerosis (MS)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis elezanumab, placebo - Multiple Sclerosis (MS) | Phase 2 | Completed | AbbVie | 123 | 2019-02-27 | 2023-12-21 |
| A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis elezanumab, placebo - Multiple Sclerosis (MS) | Phase 2 | Completed | AbbVie | 208 | 2018-12-11 | 2023-12-22 |
| Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis Mesenchymal stem cells - Multiple Sclerosis (MS) | Phase 2 | Completed | Dimitrios Karussis | 48 | 2015-01-29 | 2019-08-01 |
Multiple Sclerosis (3) · Multiple Sclerosis, Chronic Progressive (1)
Autoimmune Diseases (3) · Autoimmune Diseases of the Nervous System (3) · Demyelinating Autoimmune Diseases, CNS (3) · Demyelinating Diseases (3) · Immune System Diseases (3) · Nervous System Diseases (3) · Chronic Disease (1) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
elezanumab (2)
AbbVie (2) · Dimitrios Karussis (1)
Canada (2) · United States (2) · Israel (1)